Capillary-wall collagen as a biophysical marker of nanotherapeutic permeability into the tumor microenvironment

Cancer Research

Volumn 74, Issue 16, 2014, Pages 4239-4246

  Yokoi, Kenji ^a,b   Kojic, Milos ^a,c   Milosevic, Miljan ^c   Tanei, Tomonori ^a   Ferrari, Mauro ^a   Ziemys, Arturas ^a  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c Institute for Medical Research   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; DOXORUBICIN; LIPOSOME; MACROGOL DERIVATIVE; NANOPARTICLE;

ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CAPILLARY; CAPILLARY PERMEABILITY; CHEMISTRY; DIFFUSION; DRUG DELIVERY SYSTEM; FEMALE; METABOLISM; MOUSE; PHYSIOLOGY; PROCEDURES; TUMOR MICROENVIRONMENT;

ANIMALS; CAPILLARIES; CAPILLARY PERMEABILITY; COLLAGEN TYPE IV; DIFFUSION; DOXORUBICIN; DRUG DELIVERY SYSTEMS; FEMALE; LIPOSOMES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NANOPARTICLES; POLYETHYLENE GLYCOLS; TUMOR MICROENVIRONMENT;

EID: 84905977650     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-13-3494     Document Type: Article

References (50)

1. Koo OM, Rubinstein I, Onyuksel H. Role of nanotechnology in targeted drug delivery and imaging: a concise review. Nanomedicine 2005;1:193-212. (Pubitemid 43963632)
2. Ferrari M. Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 2005;5:161-71. (Pubitemid 40314948)
3. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2007;2:751-60. (Pubitemid 350223348)
4. Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 2000;65:271-84. (Pubitemid 30122932)
5. Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986;46:6387-92. (Pubitemid 17221789)
6. Yuan F. Transvascular drug delivery in solid tumors. Semin Radiat Oncol 1998;8:164-175. (Pubitemid 28323475)
7. Michor F, Liphardt J, Ferrari M, Widom J. What does physics have to do with cancer? Nat Rev Cancer 2011;11:657-70.
8. Ferrari M. Frontiers in cancer nanomedicine: directing mass transport through biological barriers. Trends Biotechnol 2010;28:181-188.
9. Yuan F, Dellian M, Fukumura D, Leunig M, Berk DA, Torchilin VP, et al. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res 1995;55:3752-6.
10. Sharom FJ. Abc multidrug transporters: structure, function and role in chemoresistance. Pharmacogenomics 2008;9:105-27. (Pubitemid 351560534)
11. Gottesman MM. Mechanisms of cancer drug resistance. Annu Rev Med 2002;53:615-27. (Pubitemid 34177898)
12. Sahay G, Alakhova DY, Kabanov AV. Endocytosis of nanomedicines. J Control Release 2010;145:182-95.
13. Simionescu M, Popov D, Sima A. Endothelial transcytosis in health and disease. Cell Tissue Res 2009;335:27-40.
14. Schechter J. Ultrastructural changes in the capillary bed of human pituitary tumors. Am J Pathol 1972;67:109.
15. Roberts WG, Palade GE. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci 1995;108:2369-79.
16. Bearer EL, Orci L. Endothelial fenestral diaphragms: a quick-freeze, deep-etch study. J Cell Biol 1985;100:418-28. (Pubitemid 15173247)
17. Yurchenco PD, Ruben GC. Basement membrane structure in situ: evidence for lateral associations in the type IV collagen network. J Cell Biol 1987;105:2559-68. (Pubitemid 18017686)
18. Ramanujan S, Pluen A, Mckee T, Brown E, Boucher Y, Jain R. Diffusion and convection in collagen gels: implications for transport in the tumor interstitium. Biophys J 2002;83:1650-60. (Pubitemid 34977735)
19. Robert A, Godeau G, Miskulin M, Moati F. Mechanism of action of collagenase on the permeability of the blood-brain barrier. Neurochem Res 1977;2:449-55. (Pubitemid 8255539)
20. Utoguchi N, Mizuguchi H, Dantakean A, Makimoto H, Wakai Y, Tsutsumi Y, et al. Effect of tumour cell-conditioned medium on endothelial macromolecular permeability and its correlation with collagen. Br J Cancer 1996;73:24.
21. Netti PA, Berk DA, Swartz MA, Grodzinsky AJ, Jain RK. Role of extracellular matrix assembly in interstitial transport in solid tumors. Cancer Res 2000;60:2497-503. (Pubitemid 30262444)
22. Yokoi K, Tanei T, Godin B, Ven AVD, Hanibuchi M, Matsunoki A, et al. Serum biomarkers for personalization of nanotherapeutics-based therapy in different tumor and organ microenvironments. Cancer Lett 2014 Apr 1;345:48-55.
23. Jain RK. Transport of molecules across tumor vasculature. Cancer Metastasis Rev 1987;6:559-93.
24. Bassingthwaighte JB, Chan ISJ, Wang C. Computationally efficient algorithms for convection-permeation-diffusion models for blood-tissue exchange. Ann Biomed Eng 1992;20:687-725.
25. Fujimori K, Covell DG, Fletcher JE, Weinstein JN. Modeling analysis of the global and microscopic distribution of immunoglobulin g, f(ab′) 2, and fab in tumors. Cancer Res 1989;49:5656-63. (Pubitemid 19256448)
26. Yokoi K, Godin B, Oborn CJ, Alexander JF, Liu X, Fidler IJ, et al. Porous silicon nanocarriers for dual targeting tumor associated endothelial cells and macrophages in stroma of orthotopic human pancreatic cancers. Cancer Lett 2013 Jul 1;334:319-27.
27. Vaage J, Donovan D, Uster P, Working P. Tumour uptake of doxorubicin in polyethylene glycol-coated liposomes and therapeutic effect against a xenografted human pancreatic carcinoma. Br J Cancer 1997;75:482.
28. Erikson A, Tufto I, Bjønnum AB, Bruland ØS, Davies CL. The impact of enzymatic degradation on the uptake of differently sized therapeutic molecules. Anticancer Res 2008;28:3557-66.
29. Lee RJ, Low PS. Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro. Biochim Biophys Acta 1995;1233:134-44.
30. Abràmoff MD, Magalhães PJ, Ram SJ. Image processing with imagej. Biophotonics Int 2004;11:36-42.
31. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Meth 2012;9:676-82.
32. Ziemys A, Kojic M, Milosevic M, Kojic N, Hussain F, Ferrari M, et al. Hierarchical modeling of diffusive transport through nanochannels by coupling molecular dynamics with finite element method. J Comput Phys 2011;230:5722-31.
33. Kojic M, Milosevic M, Kojic N, Ferrari M, Ziemys A. On diffusion in nanospace. J Serb Soc Comput Mech 2011;5:104-18.
34. Kojic M, Ziemys A, Milosevic M, Isailovic V, Kojic N, Rosic M, et al. Transport in biological systems. J Serb Soc Comput Mech 2011;5:101-28.
35. Kojic M, Milosevic M, Kojic N, Kim K, Ferrari M, Ziemys A. A multiscale md-fe model of diffusion in composite media with internal surface interaction based on numerical homogenization procedure. Comput Methods Appl Mech Eng 2014;269:123-38.
36. Eberhard A, Kahlert S, Goede V, Hemmerlein B, Plate KH, Augustin HG. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. Cancer Res 2000;60:1388-93. (Pubitemid 30152012)
37. Timpl R, Wiedemann H, Delden V, Furthmayr H, Kuhn K. A network model for the organization of type IV collagen molecules in basement membranes. Eur J Biochem 1981;120:203-11. (Pubitemid 12221838)
38. Van Der Rest M, Garrone R. Collagen family of proteins. FASEB J 1991;5:2814-23. (Pubitemid 21892853)
39. Laurie G, Leblond C, Martin G. Localization of type IV collagen, laminin, heparan sulfate proteoglycan, and fibronectin to the basal lamina of basement membranes. J Cell Biol 1982;95:340-4. (Pubitemid 13197105)
40. Barenholz YC. Doxil® - the first FDA-approved nano-drug: lessons learned. J Control Release 2012;160:117-34.
41. Junping W, Maitani Y, Takayama K, Nagai T. In vivo evaluation of doxorubicin carried with long circulating and remote loading proliposome. Int J Pharm 2000;203:61-9. (Pubitemid 30627626)
42. Laginha KM, Verwoert S, Charrois GJ, Allen TM. Determination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumors. Clin Cancer Res 2005;11:6944-9. (Pubitemid 41428752)
43. Cretu A, Roth JM, Caunt M, Akalu A, Policarpio D, Formenti S, et al. Disruption of endothelial cell interactions with the novel hu177 cryptic collagen epitope inhibits angiogenesis. Clin Cancer Res 2007;13:3068-78. (Pubitemid 46849584)
44. Baluk P, Morikawa S, Haskell A, Mancuso M, Mcdonald DM. Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors. Am J Pathol 2003;163:1801-15. (Pubitemid 37310012)
45. Yuan F, Leunig M, Huang SK, Berk DA, Papahadjopoulos D, Jain RK. Mirovascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. Cancer Res 1994;54:3352-6. (Pubitemid 24225946)
46. Ishida O, Maruyama K, Sasaki K, Iwatsuru M. Size-dependent extravasation and interstitial localization of polyethyleneglycol liposomes in solid tumor-bearing mice. Int J Pharm 1999;190:49-56. (Pubitemid 29467471)
47. Inai T, Mancuso M, Hashizume H, Baffert F, Haskell A, Baluk P, et al. Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts. Am J Pathol 2004;165:35-52. (Pubitemid 38821812)
48. Gaumet M, Vargas A, Gurny R, Delie F. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. Eur J Pharm Biopharm 2008;69:1-9. (Pubitemid 351467152)
49. Jain RK, Stylianopoulos T. Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol 2010;7:653-664.
50. Davis ME. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 2008;7:771-82.